Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2019.0284


Static and dynamic genome and transcriptome analysis with bulk NGS.

P. Antoniou, MD.


The validity of Next Generation Sequencing (NGS) technologies to identify genetic, genomic and transcriptional heterogeneity in clinical cancer samples raises the potential of individualized breast cancer treatment. Although this research strategy has already provided exiting findings many challenges remain to translate NGS-based outcomes into clinical precision oncology for breast cancer. Static and spatiotemporal genome and transcriptome analysis have already identified new cancer genes, novel oncotargets as well as the development of dynamic intratumor heterogeneity and serial circulating cell-free DNA as predictive biomarkers to guide optimal individualized therapy. Emerging clinic-genomic trials are required to validate this promising data.

(Citation: Gastric & Breast Cancer 2019; 14(1): 56-72)



You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €35 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 31 May 2019